McCann Healthcare Loses Avodart to Cramer-Krasselt

avodart.jpg

McCann Healthcare has lost the Avodart account, a GlaxoSmithKline product that helps relieve problems associated with an enlarged prostate. The account has landed with Cramer-Krasselt, we’ve confirmed with a source close to the matter.

We’re told that this does not affect other GSK accounts held by McCann.

More:Curt Detweiler to EVP/ECD at McCann North America

MEDIABISTRO EVENTS

Launch a Successful Social Media Campaign

Join Baratunde Thurston (left), The Onion’s Director of Digital and author of How to Be Black, for an entertaining look at creative social media campaigns in our Social Media Marketing Boot Camp starting this Thursday, February 16. Other speakers include Morin Oluwole (Facebook), Michael Brito (Edelman Digital), and Tim Devane (bitly). Register now.